A federal health agency is taking steps to examine whether medical marijuana can help end America’s addiction to prescription painkillers.
The National Institutes of Health (NIH) has announced a five-year, $3.8 million grant awarded to researchers at the Albert Einstein College of Medicine and Montefiore Health System to conduct the first long-term study to test whether medical marijuana reduces opioid use among adults with chronic pain.
“There is a lack of information about the impact of medical marijuana on opioid use in those with chronic pain,” says Dr. Chinazo Cunningham, associate chief of general internal medicine at Einstein and Montefiore and principal investigator on the grant. “We hope this study will fill in the gaps and provide doctors and patients with some much needed guidance.”
The study will mark the first federally funded attempt to research whether medical cannabis use can reduce